Clinical significance and prospective mechanism of increased CDKN2A expression in small cell lung cancer.

Dong-Ming LiGuo-Sheng LiJian-Di LiFeng ChenHong HuangWan-Ying HuangZhi-Guang HuangYi-Wu DangYu-Lu TangZhong-Qing TangWen-Jia TangGang ChenHui-Ping Lu

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)

CDKN2A upregulation extensively enhances the carcinogenesis and progression of SCLC.

Keyphrases

poor prognosis
small cell lung cancer
long non coding rna
multidrug resistant
brain metastases
signaling pathway
binding protein